[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371503-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371503-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unravelling-t-cell-exhaustion-through-co-inhibitory-receptors-and-its-transformative-role-in-cancer-immunotherapy","Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy","","Persistent stimulation by cancer antigens drives T lymphocyte exhaustion, marked by increased expression of co-inhibitory receptors, including PD-1, CTLA-4, LAG-3, TIM-3 and TIGIT. Through distinct molecular pathways, these receptors jointly suppress T-cell function, enabling immune evasion and supporting tumour progression. The review summarizes the therapeutic value of immune checkpoint inhibitors for reversing exhaustion, while mapping key mechanisms and functional roles of these receptors in tumourigenesis. It further evaluates synergistic combinations of ICIs with other strategies and highlights bispecific antibodies as a promising clinical frontier.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unravelling-t-cell-exhaustion-through-co-inhibitory-receptors-and-its-transformative-role-in-cancer-immunotherapy/371503/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unravelling-t-cell-exhaustion-through-co-inhibitory-receptors-and-its-transformative-role-in-cancer-immunotherapy/371503.png","ImageObject",300,407,{"name":42,"@type":43},"Maya Linwood","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What causes T cell exhaustion in cancer?","Question",{"text":63,"@type":64},"Persistent stimulation by cancer antigens drives T-cell exhaustion and up-regulates multiple co-inhibitory receptors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which co-inhibitory receptors are highlighted in this review?",{"text":68,"@type":64},"The review focuses on five major co-inhibitory receptors: PD-1, CTLA-4, LAG-3, TIM-3 and TIGIT.",{"name":70,"@type":61,"acceptedAnswer":71},"How do immune checkpoint inhibitors relate to reversing exhaustion?",{"text":72,"@type":64},"Checkpoint inhibitors (ICIs) are discussed as therapeutics that can reverse T-cell exhaustion, improving anti-tumour immune function.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371503,1790296582,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10.1002/ctm2.70345  \nREVIEW  \nUnravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy  \nSimin Xiang1  Sen Li2  Junfen Xu1   \n1 Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n2Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \nCorrespondence  \nJunfen Xu, Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China. [Email:](Email: xjfzu@zju.edu.cn)[ xjfzu@zju.edu.cn](Email: xjfzu@zju.edu.cn)  \nGraphical Abstract  \n1. This review discusses five major co-inhibitory receptors (PD-1, CTLA-4, LAG- 3, TIM-3 and TIGIT) and their related mechanisms ofT cell exhaustion in the tumour environment.  \n2. We also discuss the clinical application of checkpoint inhibitors (ICIs) in cancer immunotherapy.  \n3. The potential of bispecific antibodies (BsAbs) in cancer immunotherapy is highlighted.  \nClin. Transl. Med. 2025;15:e70345 .  \n[https://doi.org/10.1002/ctm2.70345](https://doi.org/10.1002/ctm2.70345)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nDOI: 10.1002/ctm2.70345  \nREVIEW  \nUnravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy  \nSimin Xiang1  Sen Li2  Junfen Xu1   \n1 Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n2Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \nCorrespondence  \nJunfen Xu, Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China. [Email:](Email: xjfzu@zju.edu.cn)[ xjfzu@zju.edu.cn](Email: xjfzu@zju.edu.cn)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Number: 82472891; Key Program of Zhejiang Province Natural Science Foundation of China, Grant/Award Number: LZ24H160001; Medical Interdisciplinary Innovation Program 2024, Zhejiang University School of Medicine; National Natural Science Fund for Young Scientists Fund Program C, Grant/Award Number: 82203621  \nAbstract  \nPersistent stimulation from cancer antigens leads to T lymphocytes (T cells) exhaustion, with up-regulated expression of co-inhibitory receptors, including programmed death-1 (PD-1), cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), lymphocyte-activation gene 3 (LAG-3), T cell immunoglobulin and mucin domain 3 (TIM-3) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). These receptors collectively impair T cell function via distinct molecular pathways, contributing to immune evasion and cancer progression. This review highlights the therapeutic promise of immune checkpoint inhibitors (ICIs) in reversing T cell exhaustion while delving into the complex molecular processes and functional works of these important co-inhibitory receptors in tumourigenesis. Additionally, we examine the synergistic effects of combining ICIs with other therapeutic strategies, which can enhance anti-tumour efficacy. Finally, the clinical implications of bispecific antibodies are highlighted, representing a promising frontier in cancer immunotherapy, that could revolutionise treatment paradigms while improving patient outcomes.  \nKEYWORDS  \nco-inhibitory receptors, exhaustion, immune checkpoint inhibitors, immunotherapy, T cell, tumour immunity  \nHighlights  \n∙ This review discusses five major co-inhibitory receptors (PD-1, CTLA-4, LAG- 3, TIM-3 and TIGIT) and their related mechanisms ofT cell exhaustion in the tumour environment.  \n∙ We also discuss the clinical application of checkpoint inhibitors (ICIs) in cancer immunotherapy.  \n∙ The potentia","cbCail3SEKIkSbSv","https://ap.wps.com/l/cbCail3SEKIkSbSv","pdf",1883576,23,"English","# Introduction\n## Cancer immunoediting and tumour immune evasion\n# T cell exhaustion in the tumour environment\n## Co-inhibitory receptors: PD-1, CTLA-4, LAG-3, TIM-3, TIGIT\n# Therapeutic strategies\n## Immune checkpoint inhibitors (ICIs)\n## Combination approaches with ICIs\n## Bispecific antibodies (BsAbs)\n# Clinical implications","[{\"question\":\"What causes T cell exhaustion in cancer?\",\"answer\":\"Persistent stimulation by cancer antigens drives T-cell exhaustion and up-regulates multiple co-inhibitory receptors.\"},{\"question\":\"Which co-inhibitory receptors are highlighted in this review?\",\"answer\":\"The review focuses on five major co-inhibitory receptors: PD-1, CTLA-4, LAG-3, TIM-3 and TIGIT.\"},{\"question\":\"How do immune checkpoint inhibitors relate to reversing exhaustion?\",\"answer\":\"Checkpoint inhibitors (ICIs) are discussed as therapeutics that can reverse T-cell exhaustion, improving anti-tumour immune function.\"}]","Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy | PDF",1790192225,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34df68c21c54d3921f5067b9fd187a82.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edf431915916bfecb569fe380933af4d.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/deba842df64e8e3f5c4266b23924c387.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91f19d70208bf43356f3674b5d469a6c.webp",980,1287]